-
Itron authorizes $200M share repurchase program over 18 months
Board authorized up to $200M stock buyback over 18 months starting May 8, 2026.
-
Itron Q1 revenue down 3% to $587M, GAAP EPS $1.18 vs $1.42, non-GAAP EPS $1.49
Revenue $587M, down 3% YoY; GAAP net income $53M ($1.18 diluted EPS), down from $65M ($1.42).
-
Itron reports unauthorized third-party access to systems; investigation ongoing, operations continue
Unauthorized access discovered April 13, 2026; response plan activated and law enforcement notified.
-
Itron prices $700M zero-coupon convertible notes due 2032, upsized; concurrent $100M share repurchase
$700M principal 0.00% convertible senior notes due 2032; initial conversion price $123.77/share (30% premium to $95.21).
-
Itron Q4 beats: GAAP EPS $2.21 vs $1.26; Non-GAAP $2.46; Revenue $572M; Guides FY26 rev $2.35-2.45B
Q4 revenue $572M (-7% YoY); GAAP net income $102M, diluted EPS $2.21 (vs $1.26).
-
Itron to acquire Locusview for $525M in cash; close expected Jan 2026
Purchase price of $525 million funded from cash on hand; working capital adjustments post-close.
-
Itron Q3 revenue down 5% to $582M, gross margin up 360 bps; acquires Urbint for $325M
GAAP diluted EPS $1.41 vs $1.70 YoY; Non-GAAP diluted EPS $1.54 vs $1.84.
-
Itron to acquire Urbint for $325M in cash, expected close Q4 2025
Purchase price $325M, funded from cash on hand.
-
Itron reports Q2 GAAP EPS $1.47, non-GAAP EPS $1.62; raises full-year 2025 outlook
GAAP net income $68M ($1.47 diluted EPS); non-GAAP diluted EPS $1.62, up $0.41 YoY.
-
Itron shareholders double authorized common shares to 150M, approve charter amendments
Authorized common stock increased from 75M to 150M shares, effective May 8, 2025.
-
Itron Q1 2025: Revenue $607M (+1%), GAAP EPS $1.42 (+$0.30), Non-GAAP EPS $1.52 (+$0.28), backlog $4.7B
Revenue $607M (+1% YoY); gross margin 35.8% (+180 bps) on favorable product mix.
-
Itron Q4 revenue $613M (+6% YoY); GAAP EPS $1.26; full-year record backlog $4.7B
Q4 revenue $613M, up 6% YoY; GAAP net income $58M ($1.26 diluted EPS); Non-GAAP EPS $1.35.
-
Itron Q3 2024: Revenue $615M (+10%), GAAP EPS $1.70, Non-GAAP EPS $1.84; guides FY24 revenue $2.428-$2.438B
Revenue of $615M (+10% YoY); gross margin 34.1% (+70 bps); GAAP net income $78M ($1.70 EPS) vs. $40M ($0.87 EPS).
-
Itron board authorizes $100M share repurchase program; appoints new CAO
David M. Wright appointed VP, Corporate Controller & Chief Accounting Officer effective Sept 19, 2024; no new compensation arrangement.
-
Itron Q2 2024 revenue $609M (+13% YoY), GAAP EPS $1.10, raises FY 2024 guidance
Revenue $609M (+13% YoY); gross margin 34.6% (+250 bps).
-
Itron prices $700M 1.375% convertible notes due 2030; conversion premium 27.5%
Issued $700M of 1.375% Convertible Senior Notes due July 15, 2030; initial purchasers exercised $105M option.
-
Itron Q1 revenue $603M (+22% YoY); GAAP EPS $1.12 vs loss year ago; guides Q2 non-GAAP EPS $0.90-1.00
Revenue $603M (+22% YoY); gross margin 34.0% (+240bps) on higher margin mix and operational efficiencies.
-
Itron Q4 revenue $577M (+23% YoY), GAAP EPS $0.96, Non-GAAP $1.23; guides FY24 rev $2.275-2.375B
Q4 revenue $577M (+23% YoY); GAAP diluted EPS $0.96 vs $0.49; Non-GAAP diluted EPS $1.23 vs $0.71.
-
Itron Q3 revenue $561M (+33% YoY), beats expectations; raises FY2023 guidance
GAAP diluted EPS $0.87 vs $0.09 YoY; Non-GAAP diluted EPS $0.98 vs $0.23.
-
Itron amends credit facility; extends maturity to Oct 2026 with conditional early date tied to convertible notes
Maturity extended to Oct 18, 2026; if convertible notes outstanding on Dec 14, 2025, accelerates to Dec 14, 2025 unless liquidity covers notes.
-
Itron Q2 revenue $541M (+25%), non-GAAP EPS $0.65; raises FY23 guidance sharply
Q2 revenue $541M (+25% YoY); GAAP net income $24M vs. loss of $37M in prior year.
-
Itron Q1 revenue $495M (+4% YoY), non-GAAP EPS $0.49 vs $0.11, backlog $4.6B
Revenue $495M (+4% YoY, +6% constant currency); gross margin 31.6% (+320 bps).
-
Itron Q4 revenue $467M (-4% YoY), GAAP EPS $0.49 vs -$1.30; backlog record $4.6B; guides FY2023 rev $1.85-1.95B
Q4 GAAP net income $22M ($0.49 diluted EPS) vs net loss of $59M (-$1.30) in prior year; non-GAAP EPS $0.71 vs $0.75.
-
Itron approves $40-45M restructuring plan; expects $14-17M annual savings
Board approved 2023 Projects restructuring plan on Feb 23, 2023; estimated pre-tax charges of $40-45M, ~95% cash.
-
Itron Q3 revenue falls 14% to $421M; Q4 guidance weak on supply constraints
Revenue $421M vs $487M YoY (-14%); gross margin 28.5% up 80 bps.
-
Itron Q2 revenue down 12%; guides FY 2022 revenue and EPS well below prior outlook
Revenue $432M (-12% YoY); GAAP net loss $37M ($0.82 loss per share) vs $33M loss year ago.
-
Itron Q1 revenue falls 9% to $475M; GAAP EPS $0.02 vs $0.30; backlog up to $3.9B
Revenue $475M, down 9% YoY; gross margin 28.4%, down 380 bps due to component costs and shortages.
-
Itron SVP, General Counsel and Corporate Secretary Sarah Hlavinka resigns effective March 31, 2022
Sarah E. Hlavinka notified Itron of her resignation on March 4, 2022, effective March 31, 2022.
-
Itron Q4 GAAP EPS $(1.30) on $486M revenue; FY2022 guidance $2.0-2.1B, EPS $1.25-$1.75
Q4 revenue $486M (-8% YoY); full-year $2.0B.
-
Itron board authorizes $100M share repurchase over 18 months
Board approved up to $100M in share repurchases over an 18-month period beginning Nov 1, 2021.
-
Itron Q3 revenue down 10% to $487M; component constraints cut ~$100M
GAAP net loss of $(2)M ($(0.04) EPS) vs $(25)M loss prior year; non-GAAP EPS $0.21 vs $0.61.
-
Itron sells gas regulator & European C&I gas metering ops to Dresser for $75M
Sale price $75M; pre-tax loss of $30-40M expected upon close in H1 2022 due to $58-62M FX translation losses.